Outcomes of Tisagenlecleucel in Lymphoma Patients With Predominant Management in an Ambulatory Setting
Sunita D. Nasta, Mitchell E. Hughes, Esin C. Namoglu, Alfred L. Garfall, Heather Difilippo, Hatcher J. Ballard, Stefan K. Barta, Elise A. Chong, Noelle V. Frey, James N. Gerson, Daniel J. Landsburg, Marco Ruella, Stephen J. Schuster, Jakub Svoboda, Elizabeth Weber, David L. Porter
Topics & Concepts
MedicineChimeric antigen receptorLymphomaAmbulatoryImmunotherapyOncologyInternal medicineAmbulatory careImmunologyIntensive care medicineHealth careCancerEconomicsEconomic growthCAR-T cell therapy researchLymphoma Diagnosis and TreatmentVirus-based gene therapy research